Search

Your search keyword '"Garcia-Gomez, Antonio"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Garcia-Gomez, Antonio" Remove constraint Author: "Garcia-Gomez, Antonio"
41 results on '"Garcia-Gomez, Antonio"'

Search Results

1. STATegra, a comprehensive multi-omics dataset of B-cell differentiation in mouse.

4. Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease

11. The Chromatin Remodeling Complex Chd4/NuRD Controls Striated Muscle Identity and Metabolic Homeostasis

12. Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis

13. Supplementary Figures from The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care

14. Supplementary Tables from The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care

16. JAK2-STAT Epigenetically Regulates Tolerized Genes in Monocytes in the First Encounter With Gram-Negative Bacterial Endotoxins in Sepsis

19. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

20. MOESM3 of Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis

21. Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis

22. SIRT1/2 orchestrate acquisition of DNA methylation and loss of histone H3 activating marks to prevent premature activation of inflammatory genes in macrophages

23. Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease

24. Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis

25. STATegra: a comprehensive multi-omics dataset of B-cell differentiation in mouse

26. Activation-induced cytidine deaminase targets SUV4-20-mediated histone H4K20 trimethylation to class-switch recombination sites

27. TET2- and TDG-mediated changes are required for the acquisition of distinct histone modifications in divergent terminal differentiation of myeloid cells

29. The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care

30. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease

31. Preclinical Activity of the Oral Proteasome Inhibitor MLN9708 in Myeloma Bone Disease

36. Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects

37. Epoxyketone-Based Proteasome Inhibitors Carfilzomib and Orally Bioavailable ONX 0912 Have Anti-Resorptive and Bone-Anabolic Activity in Addition to Anti-Myeloma Effects

38. Reversibility of the Resistance to Lenalidomide and Pomalidomide and Absence of Cross-Resistance in a Murine Model of MM

39. Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma

40. Dasatinib Promotes Osteoprogenitor Differentiation and Inhibition of Osteoclastogenesis: Rationale for Treatment of Myeloma Bone Disease.

41. Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma.

Catalog

Books, media, physical & digital resources